Table 1.
Association between circEPSTI1 and clinicopathological characteristics in triple-negative breast cancer
| Variables | Cases (n=240) | CircEPSTI1 | P value | |
|---|---|---|---|---|
| Low No. (%) |
High No. (%) |
|||
| Age (years) | 0.285 | |||
| ≤50 | 145 | 91(62.8%) | 54(37.2%) | |
| >50 | 95 | 66(69.5%) | 29(30.5%) | |
| Menopause | 0.375 | |||
| no | 144 | 91(63.2%) | 53(36.8%) | |
| yes | 96 | 66(68.8%) | 30(31.3%) | |
| Tumor size | <0.001* | |||
| ≤2.0 cm | 66 | 59(89.4%) | 7(10.6%) | |
| >2.0 cm | 174 | 98(56.3%) | 76(43.7%) | |
| Lymph node infiltrated | 0.004* | |||
| No | 123 | 91(74.0%) | 32(26.0%) | |
| Yes | 117 | 66(56.4%) | 51(43.6%) | |
| TNM staging | 0.008* | |||
| I- II | 188 | 131(69.7%) | 57(30.3%) | |
| III- IV | 52 | 26(50.0%) | 26(50.0%) | |
| Histological grade | 0.640a | |||
| G1 | 3 | 3(100.0%) | 0(0.0%) | |
| G2 | 141 | 93(66.0%) | 48(34.0%) | |
| G3 | 96 | 61(63.5%) | 35(36.5%) | |
a. Using Fisher's exact test
* P < 0.05, statistically significant.